HJ Research delivers in-depth insights on the global Drug Discovery Services market in its upcoming report titled, Global Drug Discovery Services Market Report 2018-2029. According to this study, the global Drug Discovery Services market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Drug Discovery Services market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Drug Discovery Services market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Drug Discovery Services industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Drug Discovery Services industry.
Global Drug Discovery Services market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Drug Discovery Services industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Drug Discovery Services market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Drug Discovery Services. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Drug Discovery Services market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Drug Discovery Services in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Drug Discovery Services market include:
Quintiles
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Market segmentation, by product types:
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Market segmentation, by applications:
Pharmaceutical Companies
Other
1 Industry Overview of Drug Discovery Services
1.1 Research Scope
1.2 Market Segmentation by Types of Drug Discovery Services
1.3 Market Segmentation by End Users of Drug Discovery Services
1.4 Market Dynamics Analysis of Drug Discovery Services
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Drug Discovery Services Industry
2.1 Quintiles
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Drug Discovery Services Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Charles River Laboratories
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Drug Discovery Services Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Aptuit
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Drug Discovery Services Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Evotec
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Drug Discovery Services Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 GenScript
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Drug Discovery Services Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 PPD
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Drug Discovery Services Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 WuXi AppTec
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Drug Discovery Services Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 AMRI
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Drug Discovery Services Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
3 Global Drug Discovery Services Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Drug Discovery Services by Regions (2018-2023)
3.2 Global Sales Revenue of Drug Discovery Services by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Drug Discovery Services by Types (2018-2023)
3.4 Global Sales Revenue of Drug Discovery Services by End Users (2018-2023)
4 Northern America Drug Discovery Services Market Analysis by Countries, Types and End Users
4.1 Northern America Drug Discovery Services Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Drug Discovery Services Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Drug Discovery Services Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Drug Discovery Services Sales Revenue Analysis (2018-2023)
4.5 Canada Drug Discovery Services Sales Revenue Analysis (2018-2023)
5 Europe Drug Discovery Services Market Analysis by Countries, Types and End Users
5.1 Europe Drug Discovery Services Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Drug Discovery Services Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Drug Discovery Services Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Drug Discovery Services Sales Revenue Analysis (2018-2023)
5.5 France Drug Discovery Services Sales Revenue Analysis (2018-2023)
5.6 UK Drug Discovery Services Sales Revenue Analysis (2018-2023)
5.7 Italy Drug Discovery Services Sales Revenue Analysis (2018-2023)
5.8 Russia Drug Discovery Services Sales Revenue Analysis (2018-2023)
5.9 Spain Drug Discovery Services Sales Revenue Analysis (2018-2023)
5.10 Netherlands Drug Discovery Services Sales Revenue Analysis (2018-2023)
6 Asia Pacific Drug Discovery Services Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Drug Discovery Services Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Drug Discovery Services Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Drug Discovery Services Sales Revenue Analysis by End Users (2018-2023)
6.4 China Drug Discovery Services Sales Revenue Analysis (2018-2023)
6.5 Japan Drug Discovery Services Sales Revenue Analysis (2018-2023)
6.6 Korea Drug Discovery Services Sales Revenue Analysis (2018-2023)
6.7 India Drug Discovery Services Sales Revenue Analysis (2018-2023)
6.8 Australia Drug Discovery Services Sales Revenue Analysis (2018-2023)
6.9 Indonesia Drug Discovery Services Sales Revenue Analysis (2018-2023)
6.10 Vietnam Drug Discovery Services Sales Revenue Analysis (2018-2023)
7 Latin America Drug Discovery Services Market Analysis by Countries, Types and End Users
7.1 Latin America Drug Discovery Services Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Drug Discovery Services Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Drug Discovery Services Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Drug Discovery Services Sales Revenue Analysis (2018-2023)
7.5 Mexico Drug Discovery Services Sales Revenue Analysis (2018-2023)
7.6 Argentina Drug Discovery Services Sales Revenue Analysis (2018-2023)
7.7 Colombia Drug Discovery Services Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Drug Discovery Services Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Drug Discovery Services Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Drug Discovery Services Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Drug Discovery Services Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Drug Discovery Services Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Drug Discovery Services Sales Revenue Analysis (2018-2023)
8.6 South Africa Drug Discovery Services Sales Revenue Analysis (2018-2023)
8.7 Egypt Drug Discovery Services Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Drug Discovery Services Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Drug Discovery Services by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Drug Discovery Services by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Drug Discovery Services by End Users (2024-2029)
10.4 Global Revenue Forecast of Drug Discovery Services by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Drug Discovery Services
11.1 Upstream Analysis of Drug Discovery Services
11.2 Downstream Major Consumers Analysis of Drug Discovery Services
11.3 Major Suppliers of Drug Discovery Services with Contact Information
11.4 Supply Chain Relationship Analysis of Drug Discovery Services
12 Drug Discovery Services New Project Investment Feasibility Analysis
12.1 Drug Discovery Services New Project SWOT Analysis
12.2 Drug Discovery Services New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Drug Discovery Services Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Drug Discovery Services
Table End Users of Drug Discovery Services
Figure Market Drivers Analysis of Drug Discovery Services
Figure Market Challenges Analysis of Drug Discovery Services
Figure Market Opportunities Analysis of Drug Discovery Services
Table Market Drivers Analysis of Drug Discovery Services
Table Quintiles Information List
Figure Drug Discovery Services Specifications of Quintiles
Table Drug Discovery Services Revenue (Million USD) and Gross Margin of Quintiles (2018-2023)
Figure Drug Discovery Services Revenue (Million USD) and Global Market Share of Quintiles (2018-2023)
Table Charles River Laboratories Information List
Figure Drug Discovery Services Specifications of Charles River Laboratories
Table Drug Discovery Services Revenue (Million USD) and Gross Margin of Charles River Laboratories (2018-2023)
Figure Drug Discovery Services Revenue (Million USD) and Global Market Share of Charles River Laboratories (2018-2023)
Table Aptuit Information List
Figure Drug Discovery Services Specifications of Aptuit
Table Drug Discovery Services Revenue (Million USD) and Gross Margin of Aptuit (2018-2023)
Figure Drug Discovery Services Revenue (Million USD) and Global Market Share of Aptuit (2018-2023)
Table Evotec Information List
Figure Drug Discovery Services Specifications of Evotec
Table Drug Discovery Services Revenue (Million USD) and Gross Margin of Evotec (2018-2023)
Figure Drug Discovery Services Revenue (Million USD) and Global Market Share of Evotec (2018-2023)
Table GenScript Information List
Figure Drug Discovery Services Specifications of GenScript
Table Drug Discovery Services Revenue (Million USD) and Gross Margin of GenScript (2018-2023)
Figure Drug Discovery Services Revenue (Million USD) and Global Market Share of GenScript (2018-2023)
Table PPD Information List
Figure Drug Discovery Services Specifications of PPD
Table Drug Discovery Services Revenue (Million USD) and Gross Margin of PPD (2018-2023)
Figure Drug Discovery Services Revenue (Million USD) and Global Market Share of PPD (2018-2023)
Table WuXi AppTec Information List
Figure Drug Discovery Services Specifications of WuXi AppTec
Table Drug Discovery Services Revenue (Million USD) and Gross Margin of WuXi AppTec (2018-2023)
Figure Drug Discovery Services Revenue (Million USD) and Global Market Share of WuXi AppTec (2018-2023)
Table AMRI Information List
Figure Drug Discovery Services Specifications of AMRI
Table Drug Discovery Services Revenue (Million USD) and Gross Margin of AMRI (2018-2023)
Figure Drug Discovery Services Revenue (Million USD) and Global Market Share of AMRI (2018-2023)
Table Global Revenue (Million USD) of Drug Discovery Services by Regions (2018-2023)
Table Global Revenue (Million USD) of Drug Discovery Services by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Drug Discovery Services by Types (2018-2023)
Table Global Revenue (Million USD) of Drug Discovery Services by End Users (2018-2023)
Table Northern America Drug Discovery Services Revenue (Million USD) by Countries (2018-2023)
Table Northern America Drug Discovery Services Revenue (Million USD) by Types (2018-2023)
Table Northern America Drug Discovery Services Revenue (Million USD) by End Users (2018-2023)
Figure United States Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Drug Discovery Services Revenue (Million USD) by Countries (2018-2023)
Table Europe Drug Discovery Services Revenue (Million USD) by Types (2018-2023)
Table Europe Drug Discovery Services Revenue (Million USD) by End Users (2018-2023)
Figure Germany Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Drug Discovery Services Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Drug Discovery Services Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Drug Discovery Services Revenue (Million USD) by End Users (2018-2023)
Figure China Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Drug Discovery Services Revenue (Million USD) by Countries (2018-2023)
Table Latin America Drug Discovery Services Revenue (Million USD) by Types (2018-2023)
Table Latin America Drug Discovery Services Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Drug Discovery Services Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Drug Discovery Services Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Drug Discovery Services Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Drug Discovery Services Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Drug Discovery Services by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Drug Discovery Services by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Drug Discovery Services by End Users (2024-2029)
Table Major Consumers with Contact Information of Drug Discovery Services
Table Major Suppliers of Drug Discovery Services with Contact Information
Figure Supply Chain Relationship Analysis of Drug Discovery Services
Table New Project SWOT Analysis of Drug Discovery Services
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Drug Discovery Services
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Drug Discovery Services Industry
Table Part of References List of Drug Discovery Services Industry
Table Units of Measurement List
Table Part of Author Details List of Drug Discovery Services Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Drug Discovery Services industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Drug Discovery Services market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Drug Discovery Services manufacturers, Drug Discovery Services raw material suppliers, Drug Discovery Services distributors as well as buyers. The primary sources from the supply side include Drug Discovery Services manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Drug Discovery Services raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Drug Discovery Services industry landscape and trends, Drug Discovery Services market dynamics and key issues, Drug Discovery Services technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Drug Discovery Services competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Drug Discovery Services market size and forecast by regions, Drug Discovery Services market size and forecast by application, Drug Discovery Services market size and forecast by types, Drug Discovery Services company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
